• It's Not Too Late to Be Part of OPA's New Conference Programming Committee
• Read OPA's Latest Blog Post: Recommended Use of Probiotics in Children
• Advocacy Roundup
• Did You Know: OPA's Basic Group Plan Provides Health Insurance for Children Attending Any Post-Secondary Institution!
• Get a Home and Auto Quote for Your Chance to Win $2,500
• It's Almost Time for the CNE! Save on Tickets with OPA
• And more

• OPA Needs Your Help: Be Part of Our New Conference Programming Committee!
• Advocacy Roundup
• TELUS Mobility Member Benefit - New Activation Promotion
• Only a Few Days Left to Register for the August Session of OPA's Aseptic Compounding Program
• Get Injection Trained with OPA's Popular Injections and Immunizations Certificate Program
• Professional Development: Live and Online
• And more

• Transparency in Health Care Consultations
• Update on Naloxone Kits Distributed Through Ontario Pharmacies
• Advocacy Roundup
• Top Five Reasons You Need Home Insurance
• Save on Summer Attractions with OPA!
• OPA's Third Party Audits: An Introduction Program Helps You Prepare for a Third Party Audit
• Professional Development: Live and Online
• And more

• Ensuring Reliable Supply of Drug Products for Resident Canadians
• Interested in Having Your MedsCheck Services Showcased as Best Practice?
• Advocacy Roundup
• Flu Season is Coming – Are You Ready? Get Injection Trained with OPA's Injections and Immunizations Certificate Program
• Interested in Learning More about Dehydration Associated with Travelling? Register for Our Complimentary Dehydration and Travel Online Module!
• Professional Development: Live and Online
• And More

• Information Regarding Markings on Fentanyl Patches
• Drug Shortage of Formulary listed Methotrexate 25 mg/mL Injection – 2 mL Vials by Sandoz Canada Inc. (DIN 02398427) and Pfizer Canada Inc. (DIN 02182777)
• Changes to Service on the Social Assistance Verification Helpline
• Advocacy Roundup
• Register Today for OPA's Drugs in Chronic Kidney Disease: Implications for Pharmacists Online Program
• Professional Development: Live and Online
• And More

• Where We’re Headed: Highlights from Conference 2017 Remarks from the CEO and Chair of the Board
• Slides from the Annual General Meeting Now Online
• Update on Injectable Sodium Bicarbonate Recall and Shortage
• DIRC is Now Offering MAiD Drug Protocol Clinical Services
• Ontario Naloxone Pharmacy Program – Naloxone Kits now available
• Paediatric Project ECHO
• Advocacy Roundup
• Save on Summer Attractions with OPA!
• Travel Affinity Summer Vacation Giveaway is on Now
• And More

Important Notice: Proposed Regulation to Enable Changes Under the Ontario Drug Benefit Act Now Open for Public Consultation

• Thanks for Making Conference 2017 a Success!
• Photos from Conference 2017 are Now Online
• Help Us Tell the Story of Pharmacists in Ontario
• Reminder: June 30 Deadline for 2017-18 UIIP Applications
• Availability and Selling of Naloxone Nasal Spray (Narcan)
• DIRC to Offer MAiD Drug Protocol Clinical Service
• Advocacy Roundup
• And more